Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy...
FDA approves new treatment for a rare genetic disorder, Fabry disease
The U.S. FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults...
TraceLink Announces Russia Compliance Solution, Designed to Meet Complex Track and Trace Requirements for Customers Supplying to Russian Market
TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
BD Drives the Future of Immunology Research with Expanded Offerings for Simultaneous RNA and Protein Expression Analysis
BD , a leading global medical technology company, announced the commercial release of the BD™ AbSeq assay to analyze protein expression at the single-cell...
Anima Biotech announces an exclusive collaboration with Lilly for the discovery and development of translation inhibitors of several protein targets
Anima Biotech announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima’s Translation Control...
Italian Pharmaceutical Manufacturer and CMO, IBI Lorenzini, Selects TraceLink to Comply with Global Serialization Regulations
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer
The European Commission has granted marketing authorisation for Tagrisso (osimertinib) as monotherapy for the 1st-line treatment of adult patients with locally-advanced or metastatic non-small...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...